Aortic valve replacement for aortic stenosis in 200 consecutive octogenarians.
From 1978 to 1992, 200 consecutive patients aged between 80 and 90 years had aortic valve replacement for calcified aortic stenosis. Valve replacement was isolated in 187 cases (93.5%), and it was in combination with coronary bypass (n = 12; 6%), mitral valve replacement (n = 1; 0.5%) or surgery of the ascending aorta (n = 4; 2%). These 200 octogenarians represented 7.4% of the 2716 patients operated for aortic stenosis during the study period. One hundred and forty-eight of them (74%) were in NYHA class III or IV. Operative mortality was 11.5% (23 deaths) and the mean duration of hospitalization was 12.7 +/- 4.83 days. After discharge, all 177 surviving patients were followed up for a mean period of 2.8 +/- 2.1 years (range one month to 10.6 years). There have been 49 deaths during the follow up. At the end of the follow up, 127 of the 128 survivors (98.6) were in NYHA classes I or II. Actuarial survival at one, three and five years was 81.7%, 74.8% and 57.14% respectively, which is equivalent to the life expectancy for subjects of the same age without aortic stenosis. It is suggested that despite the increased, yet acceptable, operative risk, valve replacement in octogenarians is justified due to its beneficial effect on life expectancy and quality of life.
Logeais
Y
Y
Clinic for Cardiovascular and Thoracic Surgery, University Hospital Center, Rennes, France.
Roussin
R
R
Langanay
T
T
Sevray
B
B
Chaperon
J
J
Leguerrier
A
A
Rioux
C
C
Corbineau
H
H
Lelong
B
B
Valla
J
J
D000206:Actuarial Analysis; D000368:Aged; D000369:Aged, 80 and over; D001011:Aorta / Q000601:surgery; D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis; D002114:Calcinosis / Q000601:surgery; D002423:Cause of Death; D001026:Coronary Artery Bypass; D005260:Female; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008017:Life Expectancy; D008297:Male; D008943:Mitral Valve / Q000601:surgery; D011474:Prosthesis Design; D011788:Quality of Life; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome